Skip to main content
PMC home page
Molecular Medicine logoLink to Molecular Medicine
. 1998 Jan;4(1):14–21.

Comorbid migraine with aura, anxiety, and depression is associated with dopamine D2 receptor (DRD2) NcoI alleles.

S J Peroutka 1, S C Price 1, T L Wilhoit 1, K W Jones 1
PMCID: PMC2230268  PMID: 9513185

Abstract

BACKGROUND: Unrelated individuals (n = 242) were interviewed directly for the presence of migraine, anxiety disorders, and major depression. MATERIALS AND METHODS: The data described in this study are derived from a clinical genetic relational database that was developed initially for the genetic analysis of migraine. Genotyping of the DRD2 NcoI C to T polymorphism located in exon 6 (His313His) was performed using previously described primers. RESULTS: A significantly increased incidence of migraine with aura (MWA), major depression, generalized anxiety disorder (GAD), panic attacks, and phobia was observed in individuals with the DRD2 NcoI C/C genotype compared with individuals with an DRD2 NcoI T allele. Specifically, 69% (91/131) of DRD2 NcoI C/C individuals in the present study met criteria for at least one of these neuropsychiatric disorders versus only 22% (4/18) of the DRD2 NcoI T/T individuals (Chi-square = 15.29; p < 0.00005). The DRD2 NcoI C allele frequency is significantly higher (Chi-square = 17.13; p < 0.00002) in individuals with MWA, anxiety disorders, and/or major depression (C allele frequency = 0.80) than in individuals who have none of these disorders (C allele frequency = 0.67). CONCLUSIONS: These data indicate that MWA, anxiety disorders, and major depression can be components of a distinct clinical syndrome associated with allelic variations within the DRD2 gene. Clinical recognition of this genetically based syndrome has significant diagnostic and therapeutic implications.

Full text

PDF
14

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amadéo S., Abbar M., Fourcade M. L., Waksman G., Leroux M. G., Madec A., Selin M., Champiat J. C., Brethome A., Leclaire Y. D2 dopamine receptor gene and alcoholism. J Psychiatr Res. 1993 Apr-Jun;27(2):173–179. doi: 10.1016/0022-3956(93)90005-m. [DOI] [PubMed] [Google Scholar]
  2. Arinami T., Itokawa M., Enguchi H., Tagaya H., Yano S., Shimizu H., Hamaguchi H., Toru M. Association of dopamine D2 receptor molecular variant with schizophrenia. Lancet. 1994 Mar 19;343(8899):703–704. doi: 10.1016/s0140-6736(94)91581-4. [DOI] [PubMed] [Google Scholar]
  3. Blum K., Noble E. P., Sheridan P. J., Finley O., Montgomery A., Ritchie T., Ozkaragoz T., Fitch R. J., Sadlack F., Sheffield D. Association of the A1 allele of the D2 dopamine receptor gene with severe alcoholism. Alcohol. 1991 Sep-Oct;8(5):409–416. doi: 10.1016/0741-8329(91)90693-q. [DOI] [PubMed] [Google Scholar]
  4. Blum K., Noble E. P., Sheridan P. J., Montgomery A., Ritchie T., Jagadeeswaran P., Nogami H., Briggs A. H., Cohn J. B. Allelic association of human dopamine D2 receptor gene in alcoholism. JAMA. 1990 Apr 18;263(15):2055–2060. [PubMed] [Google Scholar]
  5. Blum K., Noble E. P., Sheridan P. J., Montgomery A., Ritchie T., Ozkaragoz T., Fitch R. J., Wood R., Finley O., Sadlack F. Genetic predisposition in alcoholism: association of the D2 dopamine receptor TaqI B1 RFLP with severe alcoholics. Alcohol. 1993 Jan-Feb;10(1):59–67. doi: 10.1016/0741-8329(93)90054-r. [DOI] [PubMed] [Google Scholar]
  6. Bolos A. M., Dean M., Lucas-Derse S., Ramsburg M., Brown G. L., Goldman D. Population and pedigree studies reveal a lack of association between the dopamine D2 receptor gene and alcoholism. JAMA. 1990 Dec 26;264(24):3156–3160. [PubMed] [Google Scholar]
  7. Breslau N., Davis G. C., Andreski P. Migraine, psychiatric disorders, and suicide attempts: an epidemiologic study of young adults. Psychiatry Res. 1991 Apr;37(1):11–23. doi: 10.1016/0165-1781(91)90102-u. [DOI] [PubMed] [Google Scholar]
  8. Breslau N., Davis G. C. Migraine, major depression and panic disorder: a prospective epidemiologic study of young adults. Cephalalgia. 1992 Apr;12(2):85–90. doi: 10.1046/j.1468-2982.1992.1202085.x. [DOI] [PubMed] [Google Scholar]
  9. Breslau N., Davis G. C. Migraine, physical health and psychiatric disorder: a prospective epidemiologic study in young adults. J Psychiatr Res. 1993 Apr-Jun;27(2):211–221. doi: 10.1016/0022-3956(93)90009-q. [DOI] [PubMed] [Google Scholar]
  10. Breslau N., Davis G. C., Schultz L. R., Peterson E. L. Joint 1994 Wolff Award Presentation. Migraine and major depression: a longitudinal study. Headache. 1994 Jul-Aug;34(7):387–393. doi: 10.1111/j.1526-4610.1994.hed3407387.x. [DOI] [PubMed] [Google Scholar]
  11. Comings D. E., Comings B. G., Muhleman D., Dietz G., Shahbahrami B., Tast D., Knell E., Kocsis P., Baumgarten R., Kovacs B. W. The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders. JAMA. 1991 Oct 2;266(13):1793–1800. [PubMed] [Google Scholar]
  12. Comings D. E., MacMurray J., Johnson P., Dietz G., Muhleman D. Dopamine D2 receptor gene (DRD2) haplotypes and the defense style questionnaire in substance abuse, Tourette syndrome, and controls. Biol Psychiatry. 1995 Jun 1;37(11):798–805. doi: 10.1016/0006-3223(94)00222-O. [DOI] [PubMed] [Google Scholar]
  13. Comings D. E., Wu S., Chiu C., Ring R. H., Gade R., Ahn C., MacMurray J. P., Dietz G., Muhleman D. Polygenic inheritance of Tourette syndrome, stuttering, attention deficit hyperactivity, conduct, and oppositional defiant disorder: the additive and subtractive effect of the three dopaminergic genes--DRD2, D beta H, and DAT1. Am J Med Genet. 1996 May 31;67(3):264–288. doi: 10.1002/(SICI)1096-8628(19960531)67:3<264::AID-AJMG4>3.0.CO;2-N. [DOI] [PubMed] [Google Scholar]
  14. Cook B. L., Wang Z. W., Crowe R. R., Hauser R., Freimer M. Alcoholism and the D2 receptor gene. Alcohol Clin Exp Res. 1992 Aug;16(4):806–809. doi: 10.1111/j.1530-0277.1992.tb00683.x. [DOI] [PubMed] [Google Scholar]
  15. Geijer T., Neiman J., Rydberg U., Gyllander A., Jönsson E., Sedvall G., Valverius P., Terenius L. Dopamine D2-receptor gene polymorphisms in Scandinavian chronic alcoholics. Eur Arch Psychiatry Clin Neurosci. 1994;244(1):26–32. doi: 10.1007/BF02279808. [DOI] [PubMed] [Google Scholar]
  16. Gejman P. V., Ram A., Gelernter J., Friedman E., Cao Q., Pickar D., Blum K., Noble E. P., Kranzler H. R., O'Malley S. No structural mutation in the dopamine D2 receptor gene in alcoholism or schizophrenia. Analysis using denaturing gradient gel electrophoresis. JAMA. 1994 Jan 19;271(3):204–208. [PubMed] [Google Scholar]
  17. Gelernter J., Goldman D., Risch N. The A1 allele at the D2 dopamine receptor gene and alcoholism. A reappraisal. JAMA. 1993 Apr 7;269(13):1673–1677. [PubMed] [Google Scholar]
  18. Gelernter J., O'Malley S., Risch N., Kranzler H. R., Krystal J., Merikangas K., Kennedy J. L., Kidd K. K. No association between an allele at the D2 dopamine receptor gene (DRD2) and alcoholism. JAMA. 1991 Oct 2;266(13):1801–1807. [PubMed] [Google Scholar]
  19. Hattori M., Nanko S., Dai X. Y., Fukuda R., Kazamatsuri H. Mismatch PCR RFLP detection of DRD2 Ser311Cys polymorphism and schizophrenia. Biochem Biophys Res Commun. 1994 Jul 29;202(2):757–763. doi: 10.1006/bbrc.1994.1995. [DOI] [PubMed] [Google Scholar]
  20. Higuchi S., Muramatsu T., Murayama M., Hayashida M. Association of structural polymorphism of the dopamine D2 receptor gene and alcoholism. Biochem Biophys Res Commun. 1994 Nov 15;204(3):1199–1205. doi: 10.1006/bbrc.1994.2590. [DOI] [PubMed] [Google Scholar]
  21. Hotamisligil G. S., Breakefield X. O. Human monoamine oxidase A gene determines levels of enzyme activity. Am J Hum Genet. 1991 Aug;49(2):383–392. [PMC free article] [PubMed] [Google Scholar]
  22. Kessler R. C., McGonagle K. A., Zhao S., Nelson C. B., Hughes M., Eshleman S., Wittchen H. U., Kendler K. S. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994 Jan;51(1):8–19. doi: 10.1001/archpsyc.1994.03950010008002. [DOI] [PubMed] [Google Scholar]
  23. Lesch K. P., Bengel D., Heils A., Sabol S. Z., Greenberg B. D., Petri S., Benjamin J., Müller C. R., Hamer D. H., Murphy D. L. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science. 1996 Nov 29;274(5292):1527–1531. doi: 10.1126/science.274.5292.1527. [DOI] [PubMed] [Google Scholar]
  24. Maquat L. E. Defects in RNA splicing and the consequence of shortened translational reading frames. Am J Hum Genet. 1996 Aug;59(2):279–286. [PMC free article] [PubMed] [Google Scholar]
  25. Marazziti D., Toni C., Pedri S., Bonuccelli U., Pavese N., Nuti A., Muratorio A., Cassano G. B., Akiskal H. S. Headache, panic disorder and depression: comorbidity or a spectrum? Neuropsychobiology. 1995;31(3):125–129. doi: 10.1159/000119182. [DOI] [PubMed] [Google Scholar]
  26. Merikangas K. R., Angst J., Isler H. Migraine and psychopathology. Results of the Zurich cohort study of young adults. Arch Gen Psychiatry. 1990 Sep;47(9):849–853. doi: 10.1001/archpsyc.1990.01810210057008. [DOI] [PubMed] [Google Scholar]
  27. Merikangas K. R., Merikangas J. R., Angst J. Headache syndromes and psychiatric disorders: association and familial transmission. J Psychiatr Res. 1993 Apr-Jun;27(2):197–210. doi: 10.1016/0022-3956(93)90008-p. [DOI] [PubMed] [Google Scholar]
  28. Merikangas K. R., Risch N. J., Merikangas J. R., Weissman M. M., Kidd K. K. Migraine and depression: association and familial transmission. J Psychiatr Res. 1988;22(2):119–129. doi: 10.1016/0022-3956(88)90076-3. [DOI] [PubMed] [Google Scholar]
  29. Neiswanger K., Hill S. Y., Kaplan B. B. Association and linkage studies of the TAQI A1 allele at the dopamine D2 receptor gene in samples of female and male alcoholics. Am J Med Genet. 1995 Aug 14;60(4):267–271. doi: 10.1002/ajmg.1320600402. [DOI] [PubMed] [Google Scholar]
  30. Noble E. P., Blum K., Khalsa M. E., Ritchie T., Montgomery A., Wood R. C., Fitch R. J., Ozkaragoz T., Sheridan P. J., Anglin M. D. Allelic association of the D2 dopamine receptor gene with cocaine dependence. Drug Alcohol Depend. 1993 Oct;33(3):271–285. doi: 10.1016/0376-8716(93)90113-5. [DOI] [PubMed] [Google Scholar]
  31. Noble E. P., Blum K., Ritchie T., Montgomery A., Sheridan P. J. Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism. Arch Gen Psychiatry. 1991 Jul;48(7):648–654. doi: 10.1001/archpsyc.1991.01810310066012. [DOI] [PubMed] [Google Scholar]
  32. Noble E. P., St Jeor S. T., Ritchie T., Syndulko K., St Jeor S. C., Fitch R. J., Brunner R. L., Sparkes R. S. D2 dopamine receptor gene and cigarette smoking: a reward gene? Med Hypotheses. 1994 Apr;42(4):257–260. doi: 10.1016/0306-9877(94)90127-9. [DOI] [PubMed] [Google Scholar]
  33. Noble E. P., Syndulko K., Fitch R. J., Ritchie T., Bohlman M. C., Guth P., Sheridan P. J., Montgomery A., Heinzmann C., Sparkes R. S. D2 dopamine receptor TaqI A alleles in medically ill alcoholic and nonalcoholic patients. Alcohol Alcohol. 1994 Nov;29(6):729–744. [PubMed] [Google Scholar]
  34. O'Hara B. F., Smith S. S., Bird G., Persico A. M., Suarez B. K., Cutting G. R., Uhl G. R. Dopamine D2 receptor RFLPs, haplotypes and their association with substance use in black and Caucasian research volunteers. Hum Hered. 1993 Jul-Aug;43(4):209–218. doi: 10.1159/000154133. [DOI] [PubMed] [Google Scholar]
  35. Parsian A., Todd R. D., Devor E. J., O'Malley K. L., Suarez B. K., Reich T., Cloninger C. R. Alcoholism and alleles of the human D2 dopamine receptor locus. Studies of association and linkage. Arch Gen Psychiatry. 1991 Jul;48(7):655–663. doi: 10.1001/archpsyc.1991.01810310073013. [DOI] [PubMed] [Google Scholar]
  36. Pato C. N., Macciardi F., Pato M. T., Verga M., Kennedy J. L. Review of the putative association of dopamine D2 receptor and alcoholism: a meta-analysis. Am J Med Genet. 1993 Jul 15;48(2):78–82. doi: 10.1002/ajmg.1320480204. [DOI] [PubMed] [Google Scholar]
  37. Peroutka S. J., Wilhoit T., Jones K. Clinical susceptibility to migraine with aura is modified by dopamine D2 receptor (DRD2) NcoI alleles. Neurology. 1997 Jul;49(1):201–206. doi: 10.1212/wnl.49.1.201. [DOI] [PubMed] [Google Scholar]
  38. Rasmussen S. A., Eisen J. L. The epidemiology and differential diagnosis of obsessive compulsive disorder. J Clin Psychiatry. 1994 Oct;55 (Suppl):5–14. [PubMed] [Google Scholar]
  39. Robins L. N., Helzer J. E., Weissman M. M., Orvaschel H., Gruenberg E., Burke J. D., Jr, Regier D. A. Lifetime prevalence of specific psychiatric disorders in three sites. Arch Gen Psychiatry. 1984 Oct;41(10):949–958. doi: 10.1001/archpsyc.1984.01790210031005. [DOI] [PubMed] [Google Scholar]
  40. Sarkar G., Kapelner S., Grandy D. K., Marchionni M., Civelli O., Sobell J., Heston L., Sommer S. S. Direct sequencing of the dopamine D2 receptor (DRD2) in schizophrenics reveals three polymorphisms but no structural change in the receptor. Genomics. 1991 Sep;11(1):8–14. doi: 10.1016/0888-7543(91)90096-w. [DOI] [PubMed] [Google Scholar]
  41. Silberstein S. D., Lipton R. B., Breslau N. Migraine: association with personality characteristics and psychopathology. Cephalalgia. 1995 Oct;15(5):358–336. doi: 10.1046/j.1468-2982.1995.1505358.x. [DOI] [PubMed] [Google Scholar]
  42. Smith S. S., O'Hara B. F., Persico A. M., Gorelick D. A., Newlin D. B., Vlahov D., Solomon L., Pickens R., Uhl G. R. Genetic vulnerability to drug abuse. The D2 dopamine receptor Taq I B1 restriction fragment length polymorphism appears more frequently in polysubstance abusers. Arch Gen Psychiatry. 1992 Sep;49(9):723–727. doi: 10.1001/archpsyc.1992.01820090051009. [DOI] [PubMed] [Google Scholar]
  43. Stewart W. F., Lipton R. B., Celentano D. D., Reed M. L. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA. 1992 Jan 1;267(1):64–69. [PubMed] [Google Scholar]
  44. Turner E., Ewing J., Shilling P., Smith T. L., Irwin M., Schuckit M., Kelsoe J. R. Lack of association between an RFLP near the D2 dopamine receptor gene and severe alcoholism. Biol Psychiatry. 1992 Feb 1;31(3):285–290. doi: 10.1016/0006-3223(92)90052-2. [DOI] [PubMed] [Google Scholar]
  45. Uhl G., Blum K., Noble E., Smith S. Substance abuse vulnerability and D2 receptor genes. Trends Neurosci. 1993 Mar;16(3):83–88. doi: 10.1016/0166-2236(93)90128-9. [DOI] [PubMed] [Google Scholar]

Articles from Molecular Medicine are provided here courtesy of The Feinstein Institute for Medical Research at North Shore LIJ

RESOURCES